Managing electrolyte abnormalities, particularly sodium and potassium, in patients with heart failure (HF) remains a concern. A novel anti-diabetic drug, sodium-glucose co-transporter-2 (SGLT2) inhibitors, has...
Authors:
Reza Amani-Beni, Bahar Darouei, Davood Shafie, Mohammadreza Mortaheb, Mohammadreza Malakoutikhah, Amirhossein Ebrahimi, Sara Heidari-Hasanabadi, Mehrdad Rabiee Rad, Ghazal Ghasempour Dabaghi, Sadegh Mazaheri-Tehrani, Ehsan Amini-Salehi, Amir Parsa Abhari and Maryam Heidarpour
Citation:
BMC Cardiovascular Disorders
2025
25:252
Content type: Systematic Review
Published on: 3 April 2025